A new study using data from the European Anaphylaxis Registry has identified important changes in which tree nuts are most likely to cause serious allergic reactions (anaphylaxis) in children and adults across…
Read more
A new study, led by King’s College London and Guy’s and St Thomas’ NHS Foundation Trust, has shown promising results, demonstrating that peanut oral immunotherapy (OIT) may be an effective treatment for…
Read more
Researchers at the University of Bristol and the James Lind Alliance invite you to take part in the second phase of a UK-wide survey to prioritise the most urgent unanswered questions about childhood food…
Read more
Last week Anaphylaxis UK celebrated National Weaning Week 2025—a time dedicated to supporting families as they introduce solid foods to their babies. We marked the occasion by publishing a podcast, offering practical,…
Read more
We are delighted to announce that Anaphylaxis UK has been successful in its application to Innovate UK for funding to set up a Knowledge Transfer Partnership (KTP) with the University of Surrey to offer support that addresses the psychological impact of living with serious allergies.
Read more
A recent study led by researchers at the Icahn School of Medicine at Mount Sinai, New York, has provided encouraging evidence that a supervised, gradual peanut ingestion protocol may help children with…
Read more
The University of Manchester is inviting individuals to participate in an event where they can share their healthcare experiences and contribute to meaningful discussions with student researchers. This research opportunity aims to…
Read more
The National Institute for Health and Care Excellence (NICE) has released its final draft guidance, recommending Acarizax for NHS use in the management of house dust mite allergy. Developed by ALK-Abello, Acarizax…
Read more
ARS Pharmaceuticals has made significant progress in expanding access to neffy®, its needle-free adrenaline (epinephrine) nasal spray. After gaining approval in the U.S. and Europe for treating severe allergic reactions like anaphylaxis,…
Read more